Nordic Pharma Drug Patent Portfolio
Nordic Pharma owns 1 orange book drug protected by 2 US patents Given below is the list of Nordic Pharma's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin | 29 Jun, 2013 | Expired |
US5763407 | High-purity desmopressin produced in large single batches | 29 Jun, 2013 | Expired |
Latest Legal Activities on Nordic Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Nordic Pharma.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Expire Patent
Critical
| 30 Apr, 2018 | US7022340 (Litigated) |
Maintenance Fee Reminder Mailed
Critical
| 13 Nov, 2017 | US7022340 (Litigated) |
Change in Power of Attorney (May Include Associate POA)
Critical
| 30 May, 2014 | US7022340 (Litigated) |
Recordation of Patent Grant Mailed
Critical
| 04 Apr, 2006 | US7022340 (Litigated) |
Patent Issue Date Used in PTA Calculation
Critical
| 04 Apr, 2006 | US7022340 (Litigated) |
Issue Notification Mailed
Critical
| 15 Mar, 2006 | US7022340 (Litigated) |
Dispatch to FDC | 03 Mar, 2006 | US7022340 (Litigated) |
Printer Rush- No mailing | 02 Feb, 2006 | US7022340 (Litigated) |
Mail Miscellaneous Communication to Applicant | 02 Feb, 2006 | US7022340 (Litigated) |
Miscellaneous Communication to Applicant - No Action Count | 31 Jan, 2006 | US7022340 (Litigated) |
Printer Rush- No mailing | 30 Jan, 2006 | US7022340 (Litigated) |
Case Docketed to Examiner in GAU
Critical
| 26 Jan, 2006 | US7022340 (Litigated) |
Case Docketed to Examiner in GAU
Critical
| 24 Jan, 2006 | US7022340 (Litigated) |
Application Is Considered Ready for Issue
Critical
| 10 Jan, 2006 | US7022340 (Litigated) |
Pubs Case Remand to TC
Critical
| 09 Jan, 2006 | US7022340 (Litigated) |
Nordic Pharma's Family Patents

Nordic Pharma Drug List
Given below is the complete list of Nordic Pharma's drugs and the patents protecting them.
1. Ddavp
Ddavp is protected by 2 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
29 Jun, 2013
(12 years ago)
| Expired |
US5763407 | High-purity desmopressin produced in large single batches |
29 Jun, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ddavp's drug page